Taiwan's Food and Drug Administration (FDA) said Monday that as a precautionary measure, it has ordered the recall of a batch of Nucala Solution for Injection, a prescription medicine used to treat severe asthma, because of a potential quality defect.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar up in Taipei trading
04/19/2024 10:24 AM - Business
Taiwan shares open lower
04/19/2024 09:09 AM - Politics
MOFA warns against trusting documents sold on dark web
04/18/2024 10:05 PM - Politics
Taiwan eyes 50% female representation in parliament: VP-elect
04/18/2024 09:51 PM - Politics
Taiwan upgrades satellite network system on Taiping Island
04/18/2024 09:22 PM